The recent development and usage of drugs aiming at PD-1 and PD-L1 have brought about monumental breakthroughs in the management of various cancers, such as melanoma, non-small cell lung cancer, kidney cancer, bladder cancer, and head and neck cancers (Lee et al., 2022[48]). This evidence concerns the gene CD274 and melanoma.